Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression

Hormone-receptor positive (HR+) breast cancer (BC) (including the luminal A and the luminal B subtypes) is the most common type of tumor in women diagnosed with early-stage BC (EBC). It represents a highly heterogeneous subgroup that is characterized by different risks of relapse. The aim of this re...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellegrino, Benedetta, Hlavata, Zuzana, Migali, Cristina, De Silva, Pushpamali, Aiello, Marco, Willard-Gallo, Karen, Musolino, Antonino, Solinas, Cinzia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249273/
https://www.ncbi.nlm.nih.gov/pubmed/33974235
http://dx.doi.org/10.1007/s40291-021-00525-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249273/
https://www.ncbi.nlm.nih.gov/pubmed/33974235
http://dx.doi.org/10.1007/s40291-021-00525-7

Ejemplares similares